UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041515
Receipt number R000047386
Scientific Title Risk factors of acute kidney injury in patients with seasonal influenza viral infection
Date of disclosure of the study information 2021/12/31
Last modified on 2024/08/25 09:53:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Risk factors of acute kidney injury in patients with seasonal influenza viral infection

Acronym

Risk factors of acute kidney injury in patients with seasonal influenza viral infection

Scientific Title

Risk factors of acute kidney injury in patients with seasonal influenza viral infection

Scientific Title:Acronym

Risk factors of acute kidney injury in patients with seasonal influenza viral infection

Region

Japan


Condition

Condition

Actue kidney injury

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine relationship between acute kidney injury and influenza viral infection

Basic objectives2

Others

Basic objectives -Others

To examine risk factors for acute kidney injury in patients with influenza viral infection

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Acute kidney injury, death

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

102 years-old >=

Gender

Male and Female

Key inclusion criteria

hospitalized patients by influenza viral infection

Key exclusion criteria

hemodialysis patient

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kento
Middle name
Last name Ishibuchi

Organization

Iwata city hospital

Division name

Renal division

Zip code

438-5000

Address

512-3, Ohkubo, Iwata, Shizuoka

TEL

0538-38-5000

Email

ishbchk@gmail.com


Public contact

Name of contact person

1st name Kento
Middle name
Last name Ishibuchi

Organization

Iwata city hospital

Division name

Renal division

Zip code

438-5000

Address

512-3, Ohkubo, Iwata, Shizuoka

TEL

0538-38-5000

Homepage URL


Email

ishbchk@gmail.com


Sponsor or person

Institute

Iwata city hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Iwata city hospital

Address

512-3, Ohkubo, Iwata, Shizuoka

Tel

0538-38-5000

Email

ishbchk@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

123

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 10 Month 01 Day

Date of IRB

2020 Year 09 Month 01 Day

Anticipated trial start date

2016 Year 10 Month 01 Day

Last follow-up date

2020 Year 09 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study design: Cohort study


Management information

Registered date

2020 Year 08 Month 22 Day

Last modified on

2024 Year 08 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047386